ArticleEJHaem2025

Donor-Derived T-Cell Redirection With Epcoritamab Achieving Complete Response After Early Post-Allo-HSCT Relapse of DLBCL.

Yoshikazu Ikoma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.